D.E. Shaw & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,000
Closed -$402K 4462
2023
Q3
$402K Sell
2,000
-14,878
-88% -$3.14M ﹤0.01% 3508
2023
Q2
$3.5M Buy
16,878
+2,794
+20% +$542K ﹤0.01% 2154
2023
Q1
$2.78M Sell
14,084
-3,958
-22% -$814K ﹤0.01% 2443
2022
Q4
$3.65M Buy
+18,042
New +$3.53M ﹤0.01% 2380
2022
Q2
Sell
-11,640
Closed -$2.64M 5568
2022
Q1
$2.64M Buy
+11,640
New +$2.74M ﹤0.01% 3027
2020
Q3
Sell
-23,280
Closed -$3.32M 4003
2020
Q2
$3.32M Buy
+23,280
New +$3.22M ﹤0.01% 1996
2018
Q2
Sell
-30,497
Closed -$4.24M 3798
2018
Q1
$4.24M Buy
+30,497
New +$4.48M 0.01% 1516

Other funds holding LH

D.E. Shaw & Co's LH Position: Q2 2025 in Review

D.E. Shaw & Co sold out of Labcorp (LH) in Q2 2025, closing a stake of 31,376 shares — an estimated $7.3M sold.

D.E. Shaw & Co first reported a position in LH in Q4 2013 and held it in 44 quarters. The position peaked at $199M in Q1 2022. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • D.E. Shaw & Co reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 31,376 Labcorp shares in Q2 2025, an estimated $7.3M.
  • D.E. Shaw & Co first reported a position in Labcorp in Q4 2013 and held it in 44 quarters.
  • D.E. Shaw & Co's Labcorp position peaked at $199M in Q1 2022.
  • 973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.